A leading biopharmaceutical company focused on discovering, developing, and commercializing innovative medicines in areas such as antiviral, oncology, and inflammatory diseases, with a strong portfolio in HIV, hepatitis, and COVID-19 therapies.
800 Bridge Parkway Redwood City CA 94065
Workers Affected
108
Notice Date
May 1, 2026
June 30, 2026
Unavailable
Permanent
Unavailable
Layoff
Unavailable
Unavailable
54 Professional, Scientific, and Technical Services
Unavailable
Unavailable
Unavailable
More WARN Notices from
